MX2018005828A - Compuestos de glucolipidos y sus usos en el tratamiento de tumores. - Google Patents

Compuestos de glucolipidos y sus usos en el tratamiento de tumores.

Info

Publication number
MX2018005828A
MX2018005828A MX2018005828A MX2018005828A MX2018005828A MX 2018005828 A MX2018005828 A MX 2018005828A MX 2018005828 A MX2018005828 A MX 2018005828A MX 2018005828 A MX2018005828 A MX 2018005828A MX 2018005828 A MX2018005828 A MX 2018005828A
Authority
MX
Mexico
Prior art keywords
tumours
treatment
glycolipids
glycolipid compounds
compounds
Prior art date
Application number
MX2018005828A
Other languages
English (en)
Inventor
Vladimirovich Bovin Nicolai
Borisovich Tuzikov Alexander
Henry Stephen
Griffiths Graham
Shaw Stephen
Yurievna Korchagina Elena
Original Assignee
Agalimmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agalimmune Ltd filed Critical Agalimmune Ltd
Publication of MX2018005828A publication Critical patent/MX2018005828A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

La invención se refiere a compuestos novedosos de glucolípidos y a composiciones farmacéuticas que comprenden dichos glucolípidos y a procedimientos para la preparación de dichos glucolípidos; la invención también se refiere a dichos glucolípidos para uso en el tratamiento de tumores y a métodos de tratamiento de tumores que usan dichos glucolípidos.
MX2018005828A 2015-11-11 2015-11-11 Compuestos de glucolipidos y sus usos en el tratamiento de tumores. MX2018005828A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2015/000766 WO2017082753A1 (en) 2015-11-11 2015-11-11 Glycolipid compounds and their uses in the treatment of tumours

Publications (1)

Publication Number Publication Date
MX2018005828A true MX2018005828A (es) 2019-02-20

Family

ID=56117941

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018005828A MX2018005828A (es) 2015-11-11 2015-11-11 Compuestos de glucolipidos y sus usos en el tratamiento de tumores.

Country Status (13)

Country Link
US (1) US20180344805A1 (es)
EP (1) EP3374367A1 (es)
JP (1) JP6758375B2 (es)
KR (1) KR102517641B1 (es)
CN (1) CN108463466B (es)
AU (1) AU2015414272B2 (es)
BR (1) BR112018009646B1 (es)
CA (1) CA3004107C (es)
HK (1) HK1258843A1 (es)
IL (1) IL259205B (es)
MX (1) MX2018005828A (es)
RU (1) RU2719486C2 (es)
WO (1) WO2017082753A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2023202155B1 (en) * 2022-04-08 2023-10-26 Kode Biotech Limited Large scale production of n-acetyllactosamine derivatives

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820628B2 (en) 2005-02-22 2010-10-26 University Of Massachusetts Medical School Tumor lesion regression and conversion in situ into autologous tumor vaccines by compositions that result in anti-Gal antibody binding
JP5580202B2 (ja) * 2007-10-12 2014-08-27 コード バイオテック リミテッド 機能性脂質構築物
KR20140038382A (ko) 2011-03-10 2014-03-28 프로벡투스 파마슈티컬스 인코포레이티드 암의 치료 증대를 위한 국소 면역조절 치료제와 전신 면역조절 치료제의 복합제
US10457706B2 (en) * 2014-11-21 2019-10-29 Stephen Micheal Henry Multivalent ligand-lipid constructs

Also Published As

Publication number Publication date
BR112018009646A2 (pt) 2018-12-11
HK1258843A1 (zh) 2019-11-22
AU2015414272A1 (en) 2018-04-26
IL259205B (en) 2021-06-30
IL259205A (en) 2018-07-31
CN108463466A (zh) 2018-08-28
BR112018009646B1 (pt) 2020-03-31
CA3004107A1 (en) 2017-05-18
KR20180099651A (ko) 2018-09-05
RU2018121273A (ru) 2019-12-13
JP2018533616A (ja) 2018-11-15
WO2017082753A1 (en) 2017-05-18
CA3004107C (en) 2023-10-17
CN108463466B (zh) 2021-07-09
RU2719486C2 (ru) 2020-04-17
AU2015414272B2 (en) 2021-04-22
KR102517641B1 (ko) 2023-04-05
EP3374367A1 (en) 2018-09-19
US20180344805A1 (en) 2018-12-06
RU2018121273A3 (es) 2019-12-13
JP6758375B2 (ja) 2020-09-23

Similar Documents

Publication Publication Date Title
MX2018008052A (es) Inhibidores de desmetilasa especifica de lisina 1 (lsd1).
IL258246B (en) Isolidine compound, pharmaceutical compositions comprising same, their combinations with therapeutic agents for use in the treatment of cancer
NZ715201A (en) Afucosylated anti-fgfr2iiib antibodies
EA036102B9 (ru) Терапевтические средства с углевод-опосредованной адресной доставкой
PH12016502249A1 (en) Pladienolide pyridine compounds and methods of use
HK1252813A1 (zh) 用於治療社交障礙和藥物使用障礙的治療性化合物和組合物
MX2017006015A (es) Composiciones para usar en el tratamiento de cancer renal.
PH12018501279A1 (en) Compositions comprising 15-hepe and methods of using the same
PL3242957T3 (pl) Kompozycje zawierające bakterie i sposoby ich wykorzystania do leczenia i/lub zapobiegania chorobom żołądkowo-jelitowym, metabolicznym i/lub innym
MX2017012595A (es) Un extracto de indigo naturalis y un proceso para preparar el mismo.
MX2017006019A (es) Apilimod para uso en el tratamiento de melanoma.
PH12016501838A1 (en) Compounds and their methods of use
MX2017010654A (es) Oxabicicloheptanos y oxabicicloheptenos para el tratamiento de trastornos depresivos y de estres.
IL248735A0 (en) Preparations containing glycolipid for use in the treatment of tumors
MX2017009608A (es) Compuestos anticancerigenos.
MX2017017119A (es) Formulacion de alta concentracion.
MX2018005828A (es) Compuestos de glucolipidos y sus usos en el tratamiento de tumores.
MY182818A (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
PL3548006T3 (pl) Kompozycja do stosowania w leczeniu zmian jelitowych
MY182809A (en) Compositions for the treatment of kidney and/or liver disease
GEP20207145B (en) Combination of trazodone and gabapentin for the treatmen
PL3319638T3 (pl) Kompozycja zawierająca cyneol do leczenia chorób nowotworowych i/lub raków
GB201513543D0 (en) Compositions for use in the treatment of diabetes
MX2017014893A (es) Composicion herbal para el tratamiento del dolor de espalda.
MX357132B (es) Uso de la inulina para el tratamiento de manifestaciones clínicas asociadas con la cirrosis hepática.